Patent: 10,071,170
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 10,071,170
Title: | Antibody-drug conjugate having improved stability and use thereof |
Abstract: | The present invention relates to an antibody-drug conjugate comprising a drug conjugated to an antibody, a preparation method thereof and the use thereof. |
Inventor(s): | Kim; Young Min (Gyeonggi-do, KR), Ko; Min Ji (Daejeon, KR), Kim; Jae Yong (Seoul, KR), Kim; Ju Hee (Daejeon, KR), Moon; Kyung Duk (Daejeon, KR), Song; Dae Hae (Daejeon, KR), Eom; Jae Hyun (Sejong, KR), Jung; Jin Won (Dajeon, KR) |
Assignee: | ABLBIO (Seoul, KR) |
Application Number: | 14/898,126 |
Patent Claims: | see list of patent claims |
Details for Patent 10,071,170
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 09/25/1998 | See Plans and Pricing | 2033-06-24 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 02/10/2017 | See Plans and Pricing | 2033-06-24 |
Genentech, Inc. | HERCEPTIN HYLECTA | trastuzumab and hyaluronidase-oysk | Injection | 761106 | 02/28/2019 | See Plans and Pricing | 2033-06-24 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |